Top Ideas

High-conviction picks generated by AI over a curated universe + live insider activity.

Last batch
1h ago
VPayments
high conv.Q-Score 96
Thesis

Visa is a near-perfect business — an asset-light, toll-road payment network with ~80% operating margins, secular tailwinds from global cash-to-digital conversion, and negligible credit risk since it never lends. The business generates enormous free cash flow that is systematically returned to shareholders via buybacks and dividends, compounding per-share value reliably through cycles. No insider selling supports a clean ownership picture.

Catalyst
Cross-border travel volume normalization continuing to recover and new payment flow verticals (B2B, government disbursements) expanding total addressable market are near-term growth drivers.
Main risk
Regulatory or antitrust intervention targeting network interchange fees — particularly in the EU or via DOJ action in the U.S. — represents the primary structural threat to the moat.
Bear
-15%
Base
+14%
Bull
+28%
NVDASemis
high conv.Q-Score 93
Thesis

NVDA remains the dominant infrastructure pick-and-shovel play on the AI capex supercycle, with hyperscalers and sovereigns competing for GPU allocation with no credible near-term alternative at scale. Business quality is exceptional — high gross margins, a full-stack moat (CUDA ecosystem), and a balance sheet that supports aggressive R&D reinvestment. No insider selling in the last 90 days removes a common overhang concern.

Catalyst
Next-generation Blackwell architecture ramp and continued hyperscaler capex guidance raises create a sequential revenue beat cycle that re-rates estimates higher.
Main risk
A sudden deceleration in hyperscaler AI infrastructure spending or a U.S. export-control tightening on advanced chips to key markets could compress forward multiples sharply.
Bear
-30%
Base
+22%
Bull
+60%
COSTRetail
medium conv.Q-Score 92
Thesis

Costco is among the highest-quality retailers globally — its membership-fee model effectively makes the merchandise business a breakeven operation that funds a loyal, high-income member base, producing remarkably stable and recurring revenue regardless of macro conditions. Renewal rates consistently above 90% and international expansion provide durable top-line growth with pricing power that most retailers cannot replicate. No insider selling in 90 days is consistent with management confidence.

Catalyst
A membership fee increase (the company's periodic lever) flowing through to high-margin fee revenue over the next 12 months acts as a direct, predictable earnings catalyst with minimal demand elasticity risk.
Main risk
A prolonged consumer trade-down that paradoxically benefits lower-ticket discount retailers, or a compression in big-ticket discretionary spending by the high-income cohort, could weigh on same-store sales growth.
Bear
-12%
Base
+12%
Bull
+25%
LLYPharma
high conv.Q-Score 89
Thesis

LLY sits at the intersection of the two most significant pharmaceutical growth vectors of the decade — GLP-1 obesity/diabetes and Alzheimer's — with Mounjaro/Zepbound and donanemab anchoring a pipeline that is rare in both breadth and commercial validation. Manufacturing capacity expansion is the primary governor on growth, meaning demand is not in question; execution on supply is. The quality of the underlying science and IP moat justifies a premium multiple.

Catalyst
Incremental manufacturing capacity coming online that reduces Zepbound supply constraints, paired with potential new GLP-1 indications (cardiovascular, renal), can accelerate revenue growth beyond current consensus.
Main risk
Political or legislative pressure on GLP-1 drug pricing (including Medicare negotiation) and any clinical setback in the obesity or Alzheimer's pipeline would materially impair the valuation.
Bear
-25%
Base
+20%
Bull
+50%
METASocial
high conv.Q-Score 88
Thesis

META has executed one of the most compelling corporate turnarounds in large-cap tech — slashing costs, rebuilding operating margins, and monetizing Reels at scale across Instagram and Facebook while adding nearly 3 billion daily actives. The advertising business benefits from AI-driven targeting improvements that are widening the gap versus peers on ROI for advertisers. No insider selling in 90 days is a neutral-to-positive signal at this scale.

Catalyst
Continued Reels monetization convergence with feed, combined with WhatsApp Business API revenue inflection, can drive another round of earnings estimate upgrades.
Main risk
Regulatory action in the EU or U.S. targeting social media advertising data practices or a forced restructuring of the family-of-apps could disrupt the core revenue engine.
Bear
-22%
Base
+18%
Bull
+45%
AVGOSemis
high conv.Q-Score 87
Thesis

AVGO is a compounding machine that combines a sticky semiconductor franchise (networking, custom ASICs) with the high-margin VMware software business now fully integrated, creating a more resilient, diversified revenue stream than most semi peers. Custom AI ASIC design wins with hyperscalers put AVGO directly in the AI infrastructure spend without NVDA's concentration risk. Capital allocation is disciplined, with consistent buybacks and a growing dividend.

Catalyst
VMware cross-sell synergies materializing ahead of schedule and new hyperscaler custom silicon design win announcements serve as near-term re-rating catalysts.
Main risk
Integration execution risk on VMware remains — customer churn from aggressive subscription migration could disappoint if enterprise pushback intensifies.
Bear
-20%
Base
+19%
Bull
+42%